Cargando…
The “Fortilat” Randomized Clinical Trial Follow-Up: Auxological Outcome at 18 Months of Age
Human milk fortification is a routine clinical practice for feeding preterm infants. We hypothesized that donkey milk can be a suitable basis for developing an innovative human milk fortifier. Our randomized controlled single-blind clinical trial, named “Fortilat”, evaluated the feeding tolerance, g...
Autores principales: | Peila, Chiara, Spada, Elena, Bertino, Enrico, Deantoni, Sonia, Percivati, Federica, Moro, Guido E., Giribaldi, Marzia, Cavallarin, Laura, Cresi, Francesco, Coscia, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761645/ https://www.ncbi.nlm.nih.gov/pubmed/33287300 http://dx.doi.org/10.3390/nu12123730 |
Ejemplares similares
-
The “Fortilat” Randomized Clinical Trial Follow-Up: Neurodevelopmental Outcome at 18 Months of Age
por: Peila, Chiara, et al.
Publicado: (2020) -
Effects on Gastroesophageal Reflux of Donkey Milk-Derived Human Milk Fortifier Versus Standard Fortifier in Preterm Newborns: Additional Data from the FortiLat Study
por: Cresi, Francesco, et al.
Publicado: (2020) -
The Effect of Holder Pasteurization on Nutrients and Biologically-Active Components in Donor Human Milk: A Review
por: Peila, Chiara, et al.
Publicado: (2016) -
Nutritional adequacy of a novel human milk fortifier from donkey milk in feeding preterm infants: study protocol of a randomized controlled clinical trial
por: Coscia, Alessandra, et al.
Publicado: (2018) -
A Novel Donkey Milk–derived Human Milk Fortifier in Feeding Preterm Infants: A Randomized Controlled Trial
por: Bertino, Enrico, et al.
Publicado: (2019)